Breaking News
Related Story
Innovent Biologics and Sanofi Enter Strategic Collaboration to Accelerate Development of Oncology Medicines and Expand Presence in China
August 8 2022
Innovent Biologics, Inc. (“Innovent”, HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes […]
Sanofi and Seagen Announce Collaboration to Develop and Commercialize Multiple Novel Antibody-drug Conjugates
March 17 2022
Sanofi and Seagen Inc. (Nasdaq:SGEN) today announced an exclusive collaboration agreement to design, develop, and commercialize antibody-drug conjugates […]
Sanofi Announces €300 Million Collaboration with Blackstone Life Sciences to Advance an Innovative Treatment for Multiple Myeloma
March 16 2022
Sanofi and Blackstone (NYSE: BX) today announced a strategic, risk-sharing collaboration under which funds managed […]
Sanofi Invests $180 Million Equity in Owkin ’s Artificial Intelligence and Federated Learning to Advance Oncology Pipeline
November 19 2021
Sanofi announced today an equity investment of $180 million and a new strategic collaboration with […]